Logo-ia
ImmunoAnalysis. 2021;1: 3 | Published on: 2021 Jul 13. doi: 10.34172/ia.2021.03

Original Research

Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells

Khalil Hajiasgharzadeh 1 ORCID, Leili Aghebati Maleki 1 ORCID, Behzad Baradaran 1, 2 * ORCID

Cited by CrossRef: 1


1- Sibuh B, Gahtori R, Al-Dayan N, Pant K, Far B, Malik A, Gupta A, Sadhu S, Dohare S, Gupta P. Emerging trends in immunotoxin targeting cancer stem cells. Toxicology in Vitro. 2022;83:105417 [Crossref]